BioSpace News Archive

CoVepiT demonstrated generation of sentinel memory T cells withlong-term protective effect against COVID-19 in preclinical and human ex vivo studies

Lysogene, a phase 3 gene therapy platform Company targeting central nervous system diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogene’s capital.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, held a virtual investor conference earlier under the invitation of KGI Securities, and provided an update on the company’s pipeline as well as corporate strategy for the year ahead.

Medtecs Group, a leading personal protective equipment supplier based in Taiwan, had passed the rigorous procurement process of the Asian Development Bank in June 2020 to become the ADB’s supplier of critical protective gear for frontline health workers risking their lives in the fight against the novel coronavirus.

Centene Corporation announced its 2021 financial guidance. Total revenues are expected to be $114.1 billion to $116.1 billion, and diluted earnings per share are expected to be $3.82 to $4.06.

Greenwich LifeSciences, Inc. announced the pricing of an upsized underwritten public offering with gross proceeds to the Company expected to be approximately $26.4 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer announced today that it has entered into a distribution agreement with Swixx BioPharma AG (“Swixx”) to be the exclusive distributor of the Company’s antibodies, DANYELZA®

Acquisition Enhances Company’s Decentralized Solutions Offering by Strengthening Patient Focus

Neutra Corporation (OTC PINK:NTRR) has enjoyed a year of important milestones and achievements that have set up the company for a strong 2021

DxTerity Diagnostics is pleased to announce a strategic collaboration with Amazon to distribute its SARS-CoV-2 diagnostic tests to U.S. small businesses and customers at home